openPR Logo
Press release

Antibiotic Resistance Market Analysis, Recent Trends And Regional Growth Forecast By Types And Applications 2021 | Allergan, AmpliPhi Biosciences, BioVersys GmbH

07-07-2021 03:14 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: QYResearch

Antibiotic Resistance Market Analysis, Recent Trends

Antibiotic Resistance market Research Report
LOS ANGELES, United States: QY Research offers an overarching research and analysis-based study on, “Global Antibiotic Resistance Industry Research Report, Growth Trends and Competitive Analysis 2021-2027“. This report offers an insightful take on the drivers and restraints present in the market. Antibiotic Resistance data reports also provide a 5 year pre-historic and forecast for the sector and include data on socio-economic data of global. Key stakeholders can consider statistics, tables & figures mentioned in this report for strategic planning which lead to success of the organization. It sheds light on strategic production, revenue, and consumption trends for players to improve sales and growth in the global Antibiotic Resistance Market. Here, it focuses on the recent developments, sales, market value, production, gross margin, and other significant factors of the business of the major players operating in the global Antibiotic Resistance Market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the global Antibiotic Resistance market.

This report includes assessment of various drivers, government policies, technological innovations, upcoming technologies, opportunities, market risks, restrains, market barriers, challenges, trends, competitive landscape, and segments which gives an exact picture of the growth of the global Antibiotic Resistance market.

Top Companies/Manufacturers:

Allergan, AmpliPhi Biosciences, BioVersys GmbH, Macrolide Pharmaceuticals, Melinta Therapeutics, Merck, Nabriva Therapeutics, Nemesis Bioscience, Phage Technologies S.A, Tetraphase Pharmaceuticals, The Medicines Company, TPfizer, Westway Health

Market Segment by Product Type:

Type I
Type II Market

Market Segment by Application:

Oxazolidinones
Lipoglycopeptides
Tetracyclines
Cephalosporins
Combination therapies
Other



Get PDF Sample Copy of the Report Antibiotic Resistance market

https://www.qyresearch.com/sample-form/form/3053257/global-antibiotic-resistance-industry

Do You Have Any Question Or Specific Requirement? Ask to Our Industry Expert:

https://www.qyresearch.com/customize-request/form/3053257/global-antibiotic-resistance-industry

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Antibiotic Resistance market.

Key questions answered in the report:

What is the growth potential of the Antibiotic Resistance market?
Which product segment will grab a lion’s share?
Which regional market will emerge as a frontrunner in the coming years?
Which application segment will grow at a robust rate?
What are the growth opportunities that may emerge in the Interactive Patient Engagement Systems industry in the years to come?
What are the key challenges that the global Antibiotic Resistance market may face in the future?
Which are the leading companies in the global Antibiotic Resistance market?
Which are the key trends positively impacting the market growth?
Which are the growth strategies considered by the players to sustain hold in the global Antibiotic Resistance market
Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Antibiotic Resistance Market Size Growth Rate by Type
1.2.2 Type I
1.2.3 Type II
1.3 Market Segment by Application
1.3.1 Global Antibiotic Resistance Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Oxazolidinones
1.3.3 Lipoglycopeptides
1.3.4 Tetracyclines
1.3.5 Cephalosporins
1.3.6 Combination therapies
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered 2 Market Perspective
2.1 Global Antibiotic Resistance Market Size (2016-2027)
2.1.1 Global Antibiotic Resistance Revenue (2016-2027)
2.1.2 Global Antibiotic Resistance Sales (2016-2027)
2.2 Global Antibiotic Resistance Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Antibiotic Resistance Sales by Regions (2016-2021)
2.2.2 Global Antibiotic Resistance Revenue by Regions (2016-2021)
2.3 Global Antibiotic Resistance Market Size Forecast by Region
2.3.1 Global Antibiotic Resistance Sales Forecast by Region (2022-2027)
2.3.2 Global Antibiotic Resistance Revenue Forecast by Region (2022-2027)
2.4 Global Top Antibiotic Resistance Regions (Countries) Ranking by Market Size
2.5 Antibiotic Resistance Industry Trends
2.5.1 Antibiotic Resistance Market Trends
2.5.2 Antibiotic Resistance Market Drivers
2.5.3 Antibiotic Resistance Market Challenges
2.5.4 Antibiotic Resistance Market Restraints 3 Competitive Landscape by Manufacturers
3.1 Global Top Antibiotic Resistance Manufacturers by Sales (2016-2021)
3.1.1 Global Antibiotic Resistance Sales by Manufacturers (2016-2021)
3.1.2 Global Antibiotic Resistance Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Antibiotic Resistance Sales in 2020
3.2 Global Top Manufacturers Antibiotic Resistance by Revenue
3.2.1 Global Antibiotic Resistance Revenue by Manufacturers (2016-2021)
3.2.2 Top Antibiotic Resistance Manufacturers Covered: Ranking by Revenue
3.2.3 Global Antibiotic Resistance Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Antibiotic Resistance Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibiotic Resistance as of 2020)
3.4 Global Antibiotic Resistance Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Antibiotic Resistance Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Antibiotic Resistance Market
3.7 Key Manufacturers Antibiotic Resistance Product Offered
3.8 Mergers & Acquisitions, Expansion Plans 4 Global Antibiotic Resistance Market Size by Type
4.1 Global Antibiotic Resistance Historic Market Review by Type (2016-2021)
4.1.1 Global Antibiotic Resistance Sales Market Share by Type (2016-2021)
4.1.2 Global Antibiotic Resistance Revenue Market Share by Type (2016-2021)
4.1.3 Antibiotic Resistance Price by Type (2016-2021)
4.2 Global Antibiotic Resistance Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Antibiotic Resistance Sales Forecast by Type (2022-2027)
4.2.2 Global Antibiotic Resistance Revenue Forecast by Type (2022-2027)
4.2.3 Antibiotic Resistance Price Forecast by Type (2022-2027) 5 Global Antibiotic Resistance Market Size by Application
5.1 Global Antibiotic Resistance Historic Market Review by Application (2016-2021)
5.1.1 Global Antibiotic Resistance Sales Market Share by Application (2016-2021)
5.1.2 Global Antibiotic Resistance Revenue Market Share by Application (2016-2021)
5.1.3 Antibiotic Resistance Price by Application (2016-2021)
5.2 Global Antibiotic Resistance Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Antibiotic Resistance Sales Forecast by Application (2022-2027)
5.2.2 Global Antibiotic Resistance Revenue Forecast by Application (2022-2027)
5.2.3 Antibiotic Resistance Price Forecast by Application (2022-2027) 6 North America
6.1 North America Antibiotic Resistance Sales Breakdown by Company
6.1.1 North America Antibiotic Resistance Sales by Company (2016-2027)
6.1.2 North America Antibiotic Resistance Revenue by Company (2016-2027)
6.2 North America Antibiotic Resistance Market Size by Type (2016-2027)
6.2.1 North America Antibiotic Resistance Sales by Type (2016-2027)
6.2.2 North America Antibiotic Resistance Revenue by Type (2016-2027)
6.3 North America Antibiotic Resistance Market Size by Application (2016-2027)
6.3.1 North America Antibiotic Resistance Sales by Application (2016-2027)
6.3.2 North America Antibiotic Resistance Revenue by Application (2016-2027)
6.4 North America Antibiotic Resistance Market Size by Country
6.4.1 North America Antibiotic Resistance Sales by Country (2016-2027)
6.4.2 North America Antibiotic Resistance Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada 7 Europe
7.1 Europe Antibiotic Resistance Sales Breakdown by Company
7.1.1 Europe Antibiotic Resistance Sales by Company (2016-2027)
7.1.2 Europe Antibiotic Resistance Revenue by Company (2016-2027)
7.2 Europe Antibiotic Resistance Market Size by Type (2016-2027)
7.2.1 Europe Antibiotic Resistance Sales by Type (2016-2027)
7.2.2 Europe Antibiotic Resistance Revenue by Type (2016-2027)
7.3 Europe Antibiotic Resistance Market Size by Application (2016-2027)
7.3.1 Europe Antibiotic Resistance Sales by Application (2016-2027)
7.3.2 Europe Antibiotic Resistance Revenue by Application (2016-2027)
7.4 Europe Antibiotic Resistance Market Size by Country
7.4.1 Europe Antibiotic Resistance Sales by Country (2016-2027)
7.4.2 Europe Antibiotic Resistance Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia 8 Asia Pacific
8.1 Asia Pacific Antibiotic Resistance Sales Breakdown by Company
8.1.1 Asia Pacific Antibiotic Resistance Sales by Company (2016-2027)
8.1.2 Asia Pacific Antibiotic Resistance Revenue by Company (2016-2027)
8.2 Asia Pacific Antibiotic Resistance Market Size by Type (2016-2027)
8.2.1 Asia Pacific Antibiotic Resistance Sales by Type (2016-2027)
8.2.2 Asia Pacific Antibiotic Resistance Revenue by Type (2016-2027)
8.3 Asia Pacific Antibiotic Resistance Market Size by Application (2016-2027)
8.3.1 Asia Pacific Antibiotic Resistance Sales by Application (2016-2027)
8.3.2 Asia Pacific Antibiotic Resistance Revenue by Application (2016-2027)
8.4 Asia Pacific Antibiotic Resistance Market Size by Regions
8.4.1 Asia Pacific Antibiotic Resistance Sales by Regions
8.4.2 Asia Pacific Antibiotic Resistance Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam 9 Latin America
9.1 Latin America Antibiotic Resistance Sales Breakdown by Company
9.1.1 Latin America Antibiotic Resistance Sales by Company (2016-2027)
9.1.2 Latin America Antibiotic Resistance Revenue by Company (2016-2027)
9.2 Latin America Antibiotic Resistance Market Size by Type (2016-2027)
9.2.1 Latin America Antibiotic Resistance Sales by Type (2016-2027)
9.2.2 Latin America Antibiotic Resistance Revenue by Type (2016-2027)
9.3 Latin America Antibiotic Resistance Market Size by Application (2016-2027)
9.3.1 Latin America Antibiotic Resistance Sales by Application (2016-2027)
9.3.2 Latin America Antibiotic Resistance Revenue by Application (2016-2027)
9.4 Latin America Antibiotic Resistance Market Size by Country
9.4.1 Latin America Antibiotic Resistance Sales by Country (2016-2027)
9.4.2 Latin America Antibiotic Resistance Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina 10 Middle East and Africa
10.1 Middle East and Africa Antibiotic Resistance Sales Breakdown by Company
10.1.1 Middle East and Africa Antibiotic Resistance Sales by Company (2016-2027)
10.1.2 Middle East and Africa Antibiotic Resistance Revenue by Company (2016-2027)
10.2 Middle East and Africa Antibiotic Resistance Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Antibiotic Resistance Sales by Type (2016-2027)
10.2.2 Middle East and Africa Antibiotic Resistance Revenue by Type (2016-2027)
10.3 Middle East and Africa Antibiotic Resistance Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Antibiotic Resistance Sales by Application (2016-2027)
10.3.2 Middle East and Africa Antibiotic Resistance Revenue by Application (2016-2027)
10.4 Middle East and Africa Antibiotic Resistance Market Size by Country
10.4.1 Middle East and Africa Antibiotic Resistance Sales by Country (2016-2027)
10.4.2 Middle East and Africa Antibiotic Resistance Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E 11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Antibiotic Resistance Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Allergan Antibiotic Resistance Products and Services
11.1.5 Allergan Antibiotic Resistance SWOT Analysis
11.1.6 Allergan Recent Developments
11.2 AmpliPhi Biosciences
11.2.1 AmpliPhi Biosciences Corporation Information
11.2.2 AmpliPhi Biosciences Overview
11.2.3 AmpliPhi Biosciences Antibiotic Resistance Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 AmpliPhi Biosciences Antibiotic Resistance Products and Services
11.2.5 AmpliPhi Biosciences Antibiotic Resistance SWOT Analysis
11.2.6 AmpliPhi Biosciences Recent Developments
11.3 BioVersys GmbH
11.3.1 BioVersys GmbH Corporation Information
11.3.2 BioVersys GmbH Overview
11.3.3 BioVersys GmbH Antibiotic Resistance Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 BioVersys GmbH Antibiotic Resistance Products and Services
11.3.5 BioVersys GmbH Antibiotic Resistance SWOT Analysis
11.3.6 BioVersys GmbH Recent Developments
11.4 Macrolide Pharmaceuticals
11.4.1 Macrolide Pharmaceuticals Corporation Information
11.4.2 Macrolide Pharmaceuticals Overview
11.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Macrolide Pharmaceuticals Antibiotic Resistance Products and Services
11.4.5 Macrolide Pharmaceuticals Antibiotic Resistance SWOT Analysis
11.4.6 Macrolide Pharmaceuticals Recent Developments
11.5 Melinta Therapeutics
11.5.1 Melinta Therapeutics Corporation Information
11.5.2 Melinta Therapeutics Overview
11.5.3 Melinta Therapeutics Antibiotic Resistance Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Melinta Therapeutics Antibiotic Resistance Products and Services
11.5.5 Melinta Therapeutics Antibiotic Resistance SWOT Analysis
11.5.6 Melinta Therapeutics Recent Developments
11.6 Merck
11.6.1 Merck Corporation Information
11.6.2 Merck Overview
11.6.3 Merck Antibiotic Resistance Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Merck Antibiotic Resistance Products and Services
11.6.5 Merck Antibiotic Resistance SWOT Analysis
11.6.6 Merck Recent Developments
11.7 Nabriva Therapeutics
11.7.1 Nabriva Therapeutics Corporation Information
11.7.2 Nabriva Therapeutics Overview
11.7.3 Nabriva Therapeutics Antibiotic Resistance Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Nabriva Therapeutics Antibiotic Resistance Products and Services
11.7.5 Nabriva Therapeutics Antibiotic Resistance SWOT Analysis
11.7.6 Nabriva Therapeutics Recent Developments
11.8 Nemesis Bioscience
11.8.1 Nemesis Bioscience Corporation Information
11.8.2 Nemesis Bioscience Overview
11.8.3 Nemesis Bioscience Antibiotic Resistance Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Nemesis Bioscience Antibiotic Resistance Products and Services
11.8.5 Nemesis Bioscience Antibiotic Resistance SWOT Analysis
11.8.6 Nemesis Bioscience Recent Developments
11.9 Phage Technologies S.A
11.9.1 Phage Technologies S.A Corporation Information
11.9.2 Phage Technologies S.A Overview
11.9.3 Phage Technologies S.A Antibiotic Resistance Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Phage Technologies S.A Antibiotic Resistance Products and Services
11.9.5 Phage Technologies S.A Antibiotic Resistance SWOT Analysis
11.9.6 Phage Technologies S.A Recent Developments
11.10 Tetraphase Pharmaceuticals
11.10.1 Tetraphase Pharmaceuticals Corporation Information
11.10.2 Tetraphase Pharmaceuticals Overview
11.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 Tetraphase Pharmaceuticals Antibiotic Resistance Products and Services
11.10.5 Tetraphase Pharmaceuticals Antibiotic Resistance SWOT Analysis
11.10.6 Tetraphase Pharmaceuticals Recent Developments
11.11 The Medicines Company
11.11.1 The Medicines Company Corporation Information
11.11.2 The Medicines Company Overview
11.11.3 The Medicines Company Antibiotic Resistance Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 The Medicines Company Antibiotic Resistance Products and Services
11.11.5 The Medicines Company Recent Developments
11.12 TPfizer
11.12.1 TPfizer Corporation Information
11.12.2 TPfizer Overview
11.12.3 TPfizer Antibiotic Resistance Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 TPfizer Antibiotic Resistance Products and Services
11.12.5 TPfizer Recent Developments
11.13 Westway Health
11.13.1 Westway Health Corporation Information
11.13.2 Westway Health Overview
11.13.3 Westway Health Antibiotic Resistance Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.13.4 Westway Health Antibiotic Resistance Products and Services
11.13.5 Westway Health Recent Developments 12 Value Chain and Sales Channels Analysis
12.1 Antibiotic Resistance Value Chain Analysis
12.2 Antibiotic Resistance Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antibiotic Resistance Production Mode & Process
12.4 Antibiotic Resistance Sales and Marketing
12.4.1 Antibiotic Resistance Sales Channels
12.4.2 Antibiotic Resistance Distributors
12.5 Antibiotic Resistance Customers 13 Research Findings and Conclusion 14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

QY Research, INC.
17890 Castleton,
Suite 218,
Los Angeles, CA - 91748
Email:
enquiry@qyresearch.com

Web:
https://www.qyresearch.com

-

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antibiotic Resistance Market Analysis, Recent Trends And Regional Growth Forecast By Types And Applications 2021 | Allergan, AmpliPhi Biosciences, BioVersys GmbH here

News-ID: 2323388 • Views: 421

More Releases from QYResearch

Nrf2 Pathway Activators Market Analysis, Recent Trends And Regional Growth Forec …
Nrf2 Pathway Activators market Research Report LOS ANGELES, United States: QY Research offers an overarching research and analysis-based study on, “Global Nrf2 Pathway Activators Industry Research Report, Growth Trends and Competitive Analysis 2021-2027“. This report offers an insightful take on the drivers and restraints present in the market. Nrf2 Pathway Activators data reports also provide a 5 year pre-historic and forecast for the sector and include data on socio-economic data
Radix Ginseng Market Analysis, Recent Trends And Regional Growth Forecast By Typ …
Radix Ginseng market Research Report LOS ANGELES, United States: QY Research offers an overarching research and analysis-based study on, “Global Radix Ginseng Industry Research Report, Growth Trends and Competitive Analysis 2021-2027“. This report offers an insightful take on the drivers and restraints present in the market. Radix Ginseng data reports also provide a 5 year pre-historic and forecast for the sector and include data on socio-economic data of global. Key
Vegan Collagen Market Analysis, Recent Trends And Regional Growth Forecast By Ty …
Vegan Collagen market Research Report LOS ANGELES, United States: QY Research offers an overarching research and analysis-based study on, “Global Vegan Collagen Industry Research Report, Growth Trends and Competitive Analysis 2021-2027“. This report offers an insightful take on the drivers and restraints present in the market. Vegan Collagen data reports also provide a 5 year pre-historic and forecast for the sector and include data on socio-economic data of global. Key
Gut Conditioner/Intestinal Conditioner Market Analysis, Recent Trends And Region …
Gut Conditioner/Intestinal Conditioner market Research Report LOS ANGELES, United States: QY Research offers an overarching research and analysis-based study on, “Global Gut Conditioner/Intestinal Conditioner Industry Research Report, Growth Trends and Competitive Analysis 2021-2027“. This report offers an insightful take on the drivers and restraints present in the market. Gut Conditioner/Intestinal Conditioner data reports also provide a 5 year pre-historic and forecast for the sector and include data on socio-economic data

All 5 Releases


More Releases for Antibiotic

Topical Antibiotic Pharmaceuticals Market Investment Research Report 2016 - 2022
Topical antibiotics pharmaceuticals are used to treat infections of the skin and are commonly applied as creams and ointments. Antibiotics are agents that destroy or inhibit the growth of microorganisms, which are sensitive to them. Few topical antibiotics are sold without prescription from physicians and are available in several forms such as ointments, creams, sprays and powders. Topical antibiotics prevents infection caused by bacteria which get into minor scrapes, burns,
Antibiotic Market Estimated to Flourish by 2016 - 2024
Global Antibiotic Market: Overview Antibiotics, also called antibacterials or antimicrobials, is a group of medicines used in the treatment of infections caused by germs—bacteria and certain parasites—by inhibiting the growth of microorganisms or killing them. Since the discovery of the antibiotic penicillin in 1920, various antibiotic compounds have been widely used to treat several bacterial infections. Increasing incidence of chronic and infectious diseases across the globe and efficacy of antibiotics to
Latest developments and breakthroughs in antibiotic resistance
The growing global threat of antimicrobial resistance, research strategies aiming to eliminate resistance, latest scientific advancements for tackling resistance, as well as potential novel candidates and antimicrobial alternatives is the focus for SMi’s 20th annual Superbugs and Superdrugs conference. It will take place in Copthorne Tara Hotel, Kensington, London on the 19th and 20th March. The topic of Superbugs & Superdrugs has continuously evolved and developed in the two decades the
Systemic Antibiotic-Sulfonamide Combination Pharmaceuticals Market Highlighted k …
Sulfonamides are a group of drugs that are derived from sulfanilamide, a sulfur containing compound. Sulfonamides are the most commonly used antibiotics around the world and have been in clinical use since 1968. Sulfonamides, also known as anti-metabolites and sulfa drugs act by inhibiting the folic acid synthesis pathway in a bacterial cell. These antibiotics are considered as selective targeted option since human do not synthesize folic acid, but a
“SPARKing" New Antibiotic Drug Discovery
Kathy Talkington, Project Director from Pew Charitable Trusts, will discuss the "Shared Platform for Antibiotic Research and Knowledge" when she presents a keynote on "SPARKing" new antibiotic drug discovery at SMi’s 20th annual conference on Superbugs and Superdrugs next March in Central London. With a background in managing and developing immunization and infectious disease programs and policies, Kathy Talkington is currently responsible for Pew’s work on antibiotics. Pew seeks to address
Research Offers 10-Year Forecast on Topical Antibiotic Pharmaceuticals Market
Topical antibiotics are applied to a certain area of the skin to kill infections. Application of topical antibiotics has a number of advantages upon comparison of systemic delivery in the treatment of skin infections. Skin and soft tissue infections (SSTIs) involve microbial invasion of the skin and underlying soft tissues infections are one of the most commonly occurring conditions amongst people. Most of these infections are minor and chronic in